Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | FYN | P06241 | 1/20 | 0.54 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.44 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 5/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL243585 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL2279126 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL4159510 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL4432263 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL3634629 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL3420431 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL20617 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL220259 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL9098767 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL344632 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115161124-B | Non-corrosive LiF cleaning agent and preparation method thereof | 福建省佑达环保材料有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-119497546-A | Stable ABX3Preparation method of perovskite semiconductor material | 浙江大学杭州国际科创中心 | 2025-02-21 | — | — | CN | disclosed |
| CN-118524849-A | Interleukin 5 binding protein dosing regimen for treatment of polyangiitis, eosinophilia syndrome, chronic sinusitis eosinophilia syndrome with nasal polyp (CRSWNP) or chronic sinusitis without nasal polyp (CRSSNP) | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-116782931-A | Use of anti-CD 40 antibodies for the treatment of inflammatory conditions | 勃林格殷格翰国际有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-115161124-B | Non-corrosive LiF cleaning agent and preparation method thereof | 福建省佑达环保材料有限公司 | 2023-09-01 | — | — | CN | disclosed |
| EP-2403536-B1 | ORAL DELIVERY OF HYDROPHILIC DRUGS TO THE BRAIN | UNIV LONDON (GB) | 2021-11-17 | — | — | EP | disclosed |
| CN-111569680-B | Polyarylether ultrafiltration membrane, nanofiltration membrane, preparation method and method for reversible conversion of ultrafiltration membrane and nanofiltration membrane | 四川大学 | 2021-03-19 | — | — | CN | disclosed |
| EP-3773662-A1 | PEPTIDE NANOFIBERS | University Of Portsmouth Higher Education Corporation (GB) | 2021-02-17 | — | — | EP | disclosed |
| US-20210038730-A1 | PEPTIDE NANOFIBERS | UNIVERSITY OF PORTSMOUTH HIGHER EDUCATION CORPORATION (GB) | 2021-02-11 | — | — | US | disclosed |
| CN-111569680-A | Polyarylether ultrafiltration membrane, nanofiltration membrane, preparation method and method for reversible conversion of ultrafiltration membrane and nanofiltration membrane | 四川大学 | 2020-08-25 | — | — | CN | disclosed |
| EP-2403536-A1 | ORAL DELIVERY OF HYDROPHILIC DRUGS TO THE BRAIN | SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (GB) | 2012-01-11 | — | — | EP | disclosed |
| US-20110218411-A1 | FLUID HANDLING CASSETTE SYSTEM FOR BODY FLUID ANALYZER | OPTISCAN BIOMEDICAL CORPORATION (US) | 2011-09-08 | — | — | US | disclosed |
| WO-2010100479-A1 | ORAL DELIVERY OF HYDROPHILIC DRUGS TO THE BRAIN | SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (GB) | 2010-09-10 | — | — | WO | disclosed |
| EP-2016402-A2 | ANTI-CLOTTING APPARATUS AND METHODS FOR FLUID HANDLING SYSTEM | Optiscan Biomedical Corporation (US) | 2009-01-21 | — | — | EP | disclosed |
| EP-1962687-A2 | FLUID HANDLING CASSETTE SYSTEM FOR BODY FLUID ANALYZER | Optiscan Biomedical Corporation (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007120746-A2 | ANTI-CLOTTING APPARATUS AND METHODS FOR FLUID HANDLING SYSTEM | OPTISCAN BIOMEDICAL CORPORATION (US) | 2007-10-25 | — | — | WO | disclosed |
| US-20070239096-A1 | ANTI-CLOTTING APPARATUS AND METHODS FOR FLUID HANDLING SYSTEM | OPTISCAN BIOMEDICAL CORPORATION (US) | 2007-10-11 | — | — | US | disclosed |
| US-20070104616-A1 | FLUID HANDLING CASSETTE SYSTEM FOR BODY FLUID ANALYZER | OPTISCAN BIOMEDICAL CORPORATION | 2007-05-10 | — | — | US | disclosed |
| WO-2007044548-A2 | FLUID HANDLING CASSETTE SYSTEM FOR BODY FLUID ANALYZER | OPTISCAN BIOMEDICAL CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
| US-4040785-A | Lysable blood preservative composition | TECHNICON INSTRUMENTS CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |